To assess the ability of LCMT‐1 to protect against cognitive impairments produced by this form of oligomeric tau, we tested the behavioral performance of LCMT‐1‐overexpressing mice and their control siblings that were treated with either sham or blast tau. This evidence concerns the gene MAPT and Cognitive impairment.